Related Experiment Video
Updated: May 8, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
The hyperleptinemia of obesity-regulator of caloric surpluses
1Touchstone Center for Diabetes Research, Department of Internal Medicine, UT Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Y8.212, Dallas, TX 75390, USA.
Abstract:
New evidence suggests that leptin and other anorexigenic agents reduce appetite by inactivating hypothalamic AMP-activated protein kinase (AMPK), thereby increasing malonyl CoA levels. This preview examines AMP biology and its role in malonyl-CoA generation and attempts to integrate its central actions with its peripheral antilipotoxic actions within the context of leptin physiology in obesity.
Related Concept Videos
Regulation of Food Intake
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Type II Diabetes II: Pathophysiology
Hypoglycemia
Hyperglycemia

